• Something wrong with this record ?

Snášenlivost a účinnost propiverinhydrochloridu u 752 pacientů s příznaky hyperaktivity detruzoru, zvýšené senzitivity a dráždivosti močového měchýře: výsledky studie sledování použití léku
[Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of hyperactivity of the detrusor, increased sensitivity and irritability of the urinary bladder: results of an investigation of the u|se of a drug]

M. Halaška, A. Martan, R. Voigt

. 1997 ; Roč. 62 (č. 5) : s. 259-264.

Language Czech Country Czech Republic

Digital library NLK
Issue
Volume
Source
Source

E-resources Online

In a post-marketing surveillance study of 752 patients suffering from urgent incontinence, mixed urgent-stress incontinence, reflex incontinence, urgency and enuresis were treated with propiverine hydrochloride. Clinical efficacy of propiyerine hydrochloride was verified by the improvement of symptoms related to detrusor hyperactivity, hypersensitivity and hyperreflexia miring a 12-week surveillance period: daytime and overnight urinary incontinence, as well as the frequency, nocturia, urgency in day time and at night decreased. These results are well demonstrated by decreased pad use and statistically significant decrease of Gaudenz urgency score during treatment, confirming the efficacy of propiverine hydrochloride already proved in clinical trials. The safety profile of propiverine hydrochloride displayed characteristic anticholinergic symptoms (dry mouth, accommodation disorders, constipation, tiredness, dizziness) with decreasing incidence during the 12-week treatment period. The residual urine volume decreased also. Serious adverse events were observed rarely and could be explained by the lack of consideration of contraindications, warnings and interactions with other drugs. The positive risk-benefit relationship of propiverine hydrochloride in the treatment of detrusor hyperactivity, hypersensitivity and hyperreflexia was reconfirmed in this post-marketing drug surveillance study.

Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of hyperactivity of the detrusor, increased sensitivity and irritability of the urinary bladder: results of an investigation of the u|se of a drug

Snášenlivost a účinnost propiverinhydrochloridu u 752 pacientů s příznaky hyperaktivity detruzoru, zvýšené senzitivity a dráždivosti močového měchýře: výsledky studie sledování použití léku = Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of hyperactivity of the detrusor, increased sensitivity and irritability of the urinary bladder: results of an investigation of the|se of a drug /

Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of hyperactivity of the detrusor, increased sensitivity and irritability of the urinary bladder: results of an investigation of the|se of a drug /

Bibliography, etc.

Lit: 28

Bibliography, etc.

Souhrn en

000      
00000naa a2200000 a 4500
001      
bmc98004130
003      
CZ-PrNML
005      
20211101121714.0
008      
971200s1997 xr u cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Halaška, Michael, $d 1947- $4 aut $7 mzk2004258380
245    10
$a Snášenlivost a účinnost propiverinhydrochloridu u 752 pacientů s příznaky hyperaktivity detruzoru, zvýšené senzitivity a dráždivosti močového měchýře: výsledky studie sledování použití léku = $b Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of hyperactivity of the detrusor, increased sensitivity and irritability of the urinary bladder: results of an investigation of the|se of a drug / $c M. Halaška, A. Martan, R. Voigt
246    11
$a Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of hyperactivity of the detrusor, increased sensitivity and irritability of the urinary bladder: results of an investigation of the u|se of a drug
314    __
$a LF UK. VFN. 1. gynekologicko-porodnická klinika, Praha, CZ
504    __
$a Lit: 28
504    __
$a Souhrn en
520    9_
$a In a post-marketing surveillance study of 752 patients suffering from urgent incontinence, mixed urgent-stress incontinence, reflex incontinence, urgency and enuresis were treated with propiverine hydrochloride. Clinical efficacy of propiyerine hydrochloride was verified by the improvement of symptoms related to detrusor hyperactivity, hypersensitivity and hyperreflexia miring a 12-week surveillance period: daytime and overnight urinary incontinence, as well as the frequency, nocturia, urgency in day time and at night decreased. These results are well demonstrated by decreased pad use and statistically significant decrease of Gaudenz urgency score during treatment, confirming the efficacy of propiverine hydrochloride already proved in clinical trials. The safety profile of propiverine hydrochloride displayed characteristic anticholinergic symptoms (dry mouth, accommodation disorders, constipation, tiredness, dizziness) with decreasing incidence during the 12-week treatment period. The residual urine volume decreased also. Serious adverse events were observed rarely and could be explained by the lack of consideration of contraindications, warnings and interactions with other drugs. The positive risk-benefit relationship of propiverine hydrochloride in the treatment of detrusor hyperactivity, hypersensitivity and hyperreflexia was reconfirmed in this post-marketing drug surveillance study.
650    _2
$a močový měchýř $x patofyziologie $7 D001743
650    _2
$a stresová inkontinence moči $x farmakoterapie $7 D014550
650    _2
$a inkontinence moči $x farmakoterapie $7 D014549
650    _2
$a benziláty $x analogy a deriváty $x aplikace a dávkování $x terapeutické užití $7 D001561
650    _2
$a parasympatolytika $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D010276
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
700    1_
$a Voigt, R. $4 aut
700    1_
$a Kaplan, F. $4 aut
700    1_
$a Rauš, K. $4 aut
700    1_
$a Mašata, Jaromír, $d 1969- $4 aut $7 mzk2004250988
700    1_
$a Klemenc, J. $4 aut
700    1_
$a Martan, Alois, $d 1952- $7 nlk20010103172
773    0_
$w MED00010981 $t Česká gynekologie $g Roč. 62, č. 5 (1997), s. 259-264 $x 1210-7832
910    __
$a ABA008 $b A 4086 $c 310 $y 0 $z 0
990    __
$a 20060528 $b ABA008
991    __
$a 20211101121726 $b ABA008
BAS    __
$a 3
BMC    __
$a 1997 $b Roč. 62 $c č. 5 $d s. 259-264 $i 1210-7832 $m Česká gynekologie $x MED00010981
LZP    __
$b přidání abstraktu

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...